Ligand validation:4XTP

A2G: 2-acetamido-2-deoxy-alpha-D-galactopyranose

A2G is a Ligand Of Interest in 4XTP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XTP_A2G_A_312	69%	74%	0.109	0.935	0.35	0.66	-	-	0	0	93%	1
4U2A_A2G_A_303	92%	40%	0.073	0.965	1.09	1.25	1	3	0	0	100%	1
4U36_A2G_A_309	91%	69%	0.067	0.967	0.47	0.72	-	-	0	0	93%	1
4XTM_A2G_A_303	59%	75%	0.171	0.953	0.45	0.52	-	-	0	0	100%	1
5T5P_A2G_b_201	100%	25%	0.036	0.982	1.15	1.89	2	3	0	0	100%	1
2CCV_A2G_A_1101	100%	23%	0.037	0.978	1.67	1.48	3	4	0	0	100%	1
2A2D_A2G_A_459	99%	12%	0.053	0.991	1.08	2.92	1	6	0	0	100%	1
5T5L_A2G_b_201	99%	57%	0.047	0.984	0.74	0.89	-	1	0	0	100%	1
5T5J_A2G_a_201	99%	42%	0.049	0.983	0.94	1.31	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.